Description
Book SynopsisCombining the important research topic of multiple bond-forming transformations with green chemistry, this book helps chemists identify recent sustainable stereoselective synthetic sequences.
Combines the important research topic of multiple bond-forming transformations with green chemistry and sustainable development
Offers a valuable resource for preparing compounds with multiple stereogenic centers, an important field for synthetic chemists
Organizes chapters by molecular structure of final products, making for a handbook-style resource
Discusses applications of the synthesis of natural products and of drug intermediates
Brings together otherwise-scattered information about a number of key, efficient chemical reactions
Table of ContentsList of Contributors xiii
Foreword xvii
Preface xix
1 Definitions and Classifications of MBFTs 1
Damien Bonne and Jean Rodriguez
1.1 Introduction 1
1.2 Definitions 4
1.3 Conclusion and Outlook 6
References 7
PART I STEREOSELECTIVE SYNTHESIS OF HETEROCYCLES 9
2 Five-Membered Heterocycles 11
Hanmin Huang and Pan Xie
2.1 Introduction 11
2.2 Monocyclic Targets 12
2.2.1 1,3-Dipolar Cycloaddition 12
2.2.2 Michael Addition-Initiated Domino Process 20
2.2.3 Multicomponent Reactions 23
2.2.4 Carbohalogenation Reactions 26
2.2.5 Radical Processes 26
2.3 Fused Polycyclic Targets 28
2.3.1 Cycloaddition Reactions 28
2.3.2 Domino Cyclization Reactions 32
2.4 Bridged Polycyclic Targets 34
2.5 Conclusion and Outlook 36
References 37
3 Six-Membered Heterocycles 45
Giammarco Tenti, M. Teresa Ramos, and J. Carlos Menéndez
3.1 Introduction 45
3.2 Monocyclic Targets 47
3.2.1 Nitrogen-Only Heterocycles 47
3.2.2 Oxygen-Containing Heterocycles 58
3.3 Fused Polycyclic Targets 62
3.3.1 Nitrogen-Only Fused Polycyclic Targets 62
3.3.2 Oxygen-Containing Fused Polycyclic Targets 70
3.3.3 Sulfur-Containing Fused Polycyclic Targets 74
3.4 Bridged Polycyclic Targets 74
3.4.1 General Procedure for the Preparation of 2,6-DABCO-Derived Compounds 138 76
3.5 Polycyclic Spiro Targets 77
3.6 Summary and Outlook 79
References 79
4 Other Heterocycles 87
Qian Wang and Jieping Zhu
4.1 Introduction 87
4.2 Synthesis of Medium-Sized Monocyclic, Fused and Bridged Polycyclic Heterocycles 88
4.2.1 Ring Synthesis by Ring Transformation via Rearrangements/Ring Expansions 88
4.2.2 Ring Synthesis by Annulation 99
4.3 Summary and Outlook 109
References 109
PART II STEREOSELECTIVE SYNTHESIS OF CARBOCYCLES 115
5 Three- and Four-Membered Carbocycles 117
Renata Marcia de Figueiredo, Gilles Niel, and Jean-Marc Campagne
5.1 Introduction 117
5.2 Cyclopropane Derivatives 118
5.2.1 Organocatalysis and Related Reactions [Michael-Initiated Ring-Closure (MIRC) Reactions] 118
5.2.2 Organometallics and Metal Catalysis 123
5.2.3 Lewis Acid-Promoted Sequences 133
5.2.4 Pericyclic Domino Strategies 134
5.2.5 Radical Domino Strategies 135
5.3 Cyclobutane Derivatives 136
5.3.1 Organocatalyzed Cyclobutanations 136
5.3.2 Organometallics and Metal Catalysis 137
5.3.3 Acid- or Base-Promoted Transformations 143
5.3.4 Multicomponent Reactions (MCRs) 145
5.4 Summary and Outlook 146
References 146
6 Five-Membered Carbocycles 157
Vijay Nair and Rony Rajan Paul
6.1 Introduction 157
6.2 Monocyclic Targets 158
6.2.1 Metal-Catalyzed Reactions 158
6.2.2 Organocatalytic Reactions 158
6.2.3 Miscellaneous Reactions 167
6.3 Fused Polycyclic Targets 169
6.3.1 Metal-Catalyzed Reactions 169
6.3.2 Organocatalytic Reactions 170
6.3.3 Lewis Acid-Catalyzed Reactions 172
6.3.4 Miscellaneous Reactions 173
6.4 Bridged Polycyclic Targets 176
6.5 Conclusion and Outlook 178
References 179
7 Stereoselective Synthesis of Six-Membered Carbocycles 185
Muriel Amatore, Corinne Aubert, Marion Barbazanges, Marine Desage-El Murr, and Cyril Ollivier
7.1 Introduction 185
7.2 Metal-Catalyzed Stereoselective Multiple Bond-Forming Transformations 186
7.2.1 Introduction 186
7.2.2 Cycloadditions 186
7.2.3 Metal-Catalyzed Cascades as Formal [2+2+2] Cycloadditions 191
7.2.4 Metal-Catalyzed Cycloisomerization Cascades 192
7.3 Enantioselective Organocatalyzed Synthesis of Six-Membered Rings 195
7.3.1 Organocatalyzed Miscellaneous Reactions 195
7.3.2 Organocatalyzed Cascade and Multicomponent Reactions 197
7.3.3 Polycyclization Cascade Reactions 201
7.4 Stereoselective Multiple Bond-Forming Radical Transformations 202
7.4.1 Intermolecular Cascade Reactions 202
7.4.2 Intramolecular Cascade Reactions 203
7.5 Conclusions 204
References 205
8 Seven- and Eight-Membered Carbocycles 211
Gérard Buono, Hervé Clavier, Laurent Giordano, and Alphonse Tenaglia
8.1 Introduction 211
8.2 Cycloheptenes 212
8.3 Cycloheptadienes 219
8.4 Cycloheptatrienes 221
8.5 Cyclooctenes 222
8.6 Cyclooctadienes 225
8.7 Cyclooctatrienes 229
8.8 Cyclooctatetraenes 234
8.9 Concluding Remarks 235
References 235
PARTIII STEREOSELECTIVE SYNTHESIS OF SPIROCYCLIC COMPOUNDS 241
9 Metal-Assisted Methodologies 243
Gaëlle Chouraqui, Laurent Commeiras, and Jean-Luc Parrain
9.1 Introduction 243
9.2 Quaternary Spirocenter 244
9.2.1 Copper-Assisted Methodologies 245
9.2.2 Gold-Assisted Methodologies 247
9.2.3 Palladium-Assisted Methodologies 247
9.2.4 Rhodium-Assisted Methodologies 251
9.2.5 Platinum-Assisted Methodologies 252
9.3 α-Heteroatom-Substituted Spirocenter 252
9.3.1 Zinc-, Magnesium-, and Copper-Assisted Methodologies 253
9.3.2 Titanium-Assisted Methodologies 254
9.3.3 Gold- and Platinum-Assisted Methodologies 255
9.3.4 Palladium-Assisted Methodologies 258
9.3.5 Rhodium-Assisted Methodologies 259
9.4 α,α′-Diheteroatom-Substituted Spirocenter 261
9.5 Conclusion and Outlook 264
References 265
10 Organocatalyzed Methodologies 271
Ramon Rios
10.1 Introduction 271
10.2 Enantioselective Synthesis of All-Carbon Spirocenters 275
10.2.1 Organocatalytic Enantioselective Methodologies for the Synthesis of Spirooxindoles 275
10.2.2 Other Spirocycles 292
10.3 Enantioselective Synthesis Spirocenters with at Least One Heteroatom 299
10.3.1 Synthesis of Spirooxindoles 299
10.3.2 Synthesis of Other Spirocycles 301
10.4 Conclusion and Outlook 301
References 302
PARTIV STEREOSELECTIVE SYNTHESIS OF ACYCLIC COMPOUNDS 307
11 Metal-Catalyzed Methodologies 309
Gabriela Guillena and Diego J. Ramón
11.1 Introduction 309
11.2 Anion Relay Approach 310
11.3 Mannich Reaction 312
11.3.1 Diastereoselective Approach 312
11.3.2 Enantioselective Approach 312
11.4 Reactions Involving Isonitriles 314
11.4.1 Diastereoselective Passerini Reaction 314
11.4.2 Enantioselective Passerini Reaction 315
11.4.3 Diastereoselective Ugi Reaction 316
11.5 1,2-Addition-Type Processes 317
11.5.1 Diastereoselective Approach 317
11.5.2 Enantioselective Approach 320
11.6 Michael-Type Processes 324
11.6.1 Diastereoselective Approach 324
11.6.2 Enantioselective Approach 327
11.7 Summary and Outlook 331
References 332
12 Organocatalyzed Methodologies 339
Vincent Coeffard, Christine Greck, Xavier Moreau, and Christine Thomassigny
12.1 Introduction 339
12.2 Aminocatalysis 340
12.2.1 Enamine–Enamine Activation 340
12.2.2 Iminium–Enamine Activation 343
12.3 N-Heterocyclic Carbene (NHC) Activation 353
12.4 H-Bonding Activation 357
12.5 Phase-Transfer Catalysis 358
12.6 Summary and Outlook 359
References 359
PART V MULTIPLE BOND-FORMING TRANSFORMATIONS: SYNTHETIC APPLICATIONS 363
13 MBFTs for the Total Synthesis of Natural Products 365
Yanxing Jia
13.1 Introduction 365
13.2 Anionic-Initiated MBFTs 366
13.3 Cationic-Initiated MBFTs 371
13.4 Radical-Mediated MBFTs 375
13.5 Pericyclic MBFTs 379
13.6 Transition-Metal-Catalyzed MBFTs 385
13.7 Summary and Outlook 388
References 390
14 Synthesis of Biologically Relevant Molecules 393
Matthijs J. van Lint, Eelco Ruijter, and Romano V.A. Orru
14.1 Introduction 393
14.2 Organocatalyzed MBFTs for BRMs 394
14.3 Multicomponent MBFTs for BRMs 404
14.4 Palladium-Catalyzed MBFTs for BRMs 413
14.5 Conclusion and Outlook 418
References 419
15 Industrial Applications of Multiple Bond-Forming Transformations (MBFTs) 423
Tryfon Zarganes-Tzitzikas, Ahmad Yazbak, Alexander Dömling
15.1 Introduction 423
15.2 Applications of MBFTs 424
15.2.1 Xylocaine 424
15.2.2 Almorexant 424
15.2.3 (−)-Oseltamivir (Tamiflu®) 427
15.2.4 Telaprevir (Incivek®) 429
15.2.5 Ezetimibe (Zetia®) 431
15.2.6 Crixivan (Indinavir®) 433
15.2.7 Oxytocine Antagonists: Retosiban and Epelsiban 436
15.2.8 Praziquantel (Biltricide®) 439
15.3 Summary and Outlook 442
References 442
Index 447
